GRB10 and metastatic neoplasm: Consistent with our immunoblotting observations under ex vivo and in vivo conditions, MEGF10, KRTAP1-1, SEMA3D, MYC, and GRB10 IHC staining revealed relatively strong positivity in metastatic tumors (Fig. 5).